Mortality and functional outcomes 18 months after hospitalization for COVID-19 in geriatric patients: a multicentric

Marion Claes1, Bastien Genet2,3, Audrey Rouet4

  • 1Service de gériatrie aigue / UPREG, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Antoine, Paris, France.

BMC Geriatrics
|September 17, 2024
PubMed

Insights

Geriatric patients hospitalized for COVID-19 did not experience higher long-term mortality compared to those hospitalized for other reasons. This study found no significant difference in mortality or functional status 18 months post-discharge.

Area of Science:

  • Geriatric Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Limited data exist on long-term outcomes for elderly patients after COVID-19 hospitalization.
  • This study addresses the long-term mortality and functional status of geriatric survivors post-COVID-19 hospitalization.

Purpose of the Study:

  • To compare 18-month mortality and functional status in geriatric patients hospitalized for COVID-19 versus other diagnoses.
  • To investigate the long-term impact of COVID-19 on elderly patient survival and independence.

Main Methods:

  • Multicenter cohort study in Paris (January-June 2021).
  • Included patients aged 75+ hospitalized with or without COVID-19.
  • Assessed vital and functional status at 18 months post-hospitalization.

Main Results:

  • COVID-19 patients were younger and less frail at baseline.
  • At 18 months, 50.8% of COVID-19 patients died vs. 66% of non-COVID-19 patients (p=0.03).
  • Multivariate analysis showed no significant association between COVID-19 and 18-month mortality; functional status did not differ.

Conclusions:

  • Positive COVID-19 status was not associated with excess long-term mortality in geriatric patients discharged alive.
  • COVID-19 hospitalization did not lead to worse long-term survival or functional decline compared to other hospitalizations in this cohort.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
182
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
179
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
162
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
177
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
243
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124